Trial intelligence / Profile preview

Pregnancy in Polycystic Ovary Syndrome

NCT00068861Phase 3Completed

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Start
Nov 2002
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in polycystic ovary syndrome (PCOS) and infertility comparing Metformin XR, Clomiphene Citrate and Metformin XR + Clomiphene Citrate (3 arms). Primary endpoint: Live birth rate at 30 weeks. Started Nov 2002; status: completed.

02

Drugs

metforminclomiphene
03

Conditions

polycystic ovary syndrome (PCOS)infertility

Beyond the preview

Go deeper on NCT00068861.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00068861.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call